期刊文献+

神经中间丝蛋白NF-66与胰岛素瘤良恶性的关系

Expression of neuronal intermediate filament protein (NF-66) and relationship with benign and malignancy of insulimomus
原文传递
导出
摘要 目的探讨神经中间丝蛋白NF-66能否作为判断胰岛素瘤良恶性的分子标志物。方法采用免疫组织化学染色法检测胰岛素瘤组织、瘤旁胰腺组织及3株胰岛素瘤细胞株NF-66蛋白的表达,应用单因素及多因素统计分析胰岛素瘤NF-66蛋白表达与肿瘤病理特征及患者预后的相关性。结果132例胰岛素瘤组织中102例(77%)表达NF-66蛋白,98例瘤旁胰腺组织均未见该蛋白表达(P=4.86×10^-3。);3株胰岛素瘤细胞株均高表达NF-66蛋白。118例良性胰岛素瘤中96例(81%)表达NF-66,而14例恶性胰岛素瘤中6例(43%)表达NF-66,恶性胰岛素瘤的表达显著下降(P=0.003)。胰岛素瘤NF.-66表达与肿瘤大小(以3cm为界)、远处转移、远处并淋巴结转移均呈显著负相关(46%比81%,P=0.009;38%比81%,P=0.013;43%比81%,P=0.010);而与患者性别、年龄、肿瘤复发和生存状态不相关。结论胰岛素瘤中NF-66表达下调与肿瘤的恶性生物学特征有关,可能成为潜在的鉴别胰岛素瘤良恶性的分子标志物。 Objective To investigate whether neuronal intermediate filament protein (NF-66) could be used as a molecular marker for the determination of malignancy of insulinoma. Methods The expression of NF-66 protein was detected in insulinoma and para - cancerous tissues and 3 insulinoma cell lines by immunohistochemistry staining. The relationship between the expression of NF-66 protein and the clinicopathological characteristics, survival was analyzed by univariate and multivariate statistical analysis. Results Expression of NF-66 was found in 102(77% ) out of 132 insulinomas and none of 98 paired control (P = 4.86 × 10^-31 ). NF-66 was highly expressed in 3 insulinoma cell lines. The expression of NF-66 was found in 96 (81%) out of 118 benign tumors (P =0.003), while out of 14 malignant insulinomas, 6(43% ) were found to express NF-66 (P = 0.003 ). The expression of NF-66 was significantly associated with tumor size (3 cm as the cut-off point), distant metastasis (38% vs 81%, P =0.013) and distant plus lymph node metastasis (46% vs 81%, P =0.009), respectively. The expression of NF-66 was not correlated with age, gender, recurrence and overall survival. Conclusions Down-regulation of NF-66 was significantly associated with tumor malignancy, suggesting that NF-66 could be a potentially novel molecular biomarker to distinguish malignancy from benign insulinoma.
出处 《中华胰腺病杂志》 CAS 2012年第2期89-91,共3页 Chinese Journal of Pancreatology
基金 国家自然科学基金(30850002、8107205) 北京协和医院卫生部内分泌重点实验室专项基金
关键词 胰岛素瘤 中间丝蛋白质类 诊断 鉴别 预后 Insulinoma Intermediate filament proteins Diagnosis, differential Prognosis
  • 相关文献

参考文献10

  • 1陈原稼;吴海燕.胰岛素瘤[A]北京:人民军医出版社,2006963-965.
  • 2Jonkers YM,Ramaekers FC,Speel EJ. Molecular alterations during insulinoma tumorigenesis[J].Biochimica Et Biophysica Acta,2007.313-332.
  • 3Modlin IM,Oberg K,Chung DC. Castroenteropancreatic neuroendocrine tumours[J].Lancet Oncology,2008,(1):61-72.doi:10.1016/S1470-2045(07)70410-2.
  • 4Gumbs AA,MoorePS,FalconiM. Review of the clinical,bistolosical,and molecular aspects of pancreatic endocrine neoplasms[J].Journal of Surgical Oncology,.
  • 5Mei M,Deng D,Liu TH. Clinical implications of microsatellite instability and MLHl gene inactivation in sporadic insulinomas[J].Journal of Clinical Endocrinology and Metabolism,2009,(9):3448-3457.doi:10.1210/jc.2009-0173.
  • 6蒋卫君,刘彤华,陈杰,高洁,武莎斐,陈原稼.胰岛素瘤频发MEN-1抑癌基因及22q的杂合缺失及其意义[J].中华医学杂志,2004,84(20):1705-1709. 被引量:9
  • 7赵玉沛,丛林,张太平,廖泉,戴梦华,刘子文,蔡力行,朱预.胰岛素瘤404例诊治分析[J].中国实用外科杂志,2008,28(5):357-359. 被引量:84
  • 8Shea TB,Beermann ML. Neuronal intermediate filament protein alpha-intemexin facilitstes axonal neurite elongation in neuroblasuma cells[J].Cell Motility and the Cytoskeleton,1999.322-333.doi:10.1002/(SICI)1097-0169(1999)43:4<322::AID-CM5>3.0.CO;2-B.
  • 9Rauch U,Klotz M,Maas-Omlor S. Expresssion of intermediate filament proteins and neuronal markers in the human fetal gut[J].Journal of Histochemistry and Cytochemistry,2006.39-46.doi:10.1369/jhc.4A6495.2005.
  • 10Foley J,Witte D,C hiu FC. Expression of the neursl intermediate filament proteins peripherin and neurofilament-66/ alpha-intemexin in neuroblastoma[J].Laboratory Investigation,1994.193-199.

二级参考文献13

  • 1张太平,赵玉沛,蔡力行,朱预.胰岛素瘤定位诊断方法的选择与评价[J].中华肝胆外科杂志,2005,11(12):818-820. 被引量:24
  • 2戴梦华,赵玉沛,廖泉,刘子文,胡亚,郭俊超.胰岛素瘤腹腔镜外科治疗体会[J].中华外科杂志,2006,44(3):165-168. 被引量:29
  • 3赵玉沛,张太平.胰岛素瘤诊断的进展[J].中国实用外科杂志,1997,17(2):74-76. 被引量:17
  • 4赵玉沛,张太平.胰岛素瘤[M]//赵玉沛.胰腺病学.北京:人民卫生出版社,2007.559-569.
  • 5Wiesli P,Brandh M,Sehmid C,et al.Selective arterial calcium stimulation and hepatic/erlott sampling in the evaluation of hyperinsulinemie hypoglycemia:potential and limitations[J].J Vase Interv Radiol,2004,15(11):1251-1256.
  • 6Hirshberg B,Libutti SK,Alexander HR,et al.Blind distal pancreatectomy for occult insulinoma,an inadvisable procedure[J].J Am Coil Sag,2002.194(6):761-764.
  • 7Lo CY,Chart WF,Lo CM,et al.Surgocal treatment of pancreatic imulinomas in the era of lapamecoy[J].Surg Endoec,2004,18(2):297-302.
  • 8Tucker ON,Crotty PL,Cordon KC.The management of insrdinoma[J].Br J Surg,2006,93(3):264-275.
  • 9Hirshberg B,Cechran C,SkandisMC,etal.Malignant inanlinoma:spectrum of unusual clinical features[J].Cancer,2005,104(2):264-272.
  • 10赵玉沛,王欣,杨波,肖毅,蔡力行,钟守先,朱预.220例胰岛素瘤诊治分析(英文)[J].中华外科杂志,2000,38(1):10-13. 被引量:44

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部